🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This gives me the courage to continue

🚨 ATOMIC- New SOC! Atezo+mFOLFOX new SOC for adjuvant therapy in stage III dMMR/MSI-H CRC 🔥 50% reduction in risk of disease recurrence. ‼️More G4 neutropenia in treatment arm. ⏰ OS not mature yet (may be affected by subsequent IO use). 🤔 Treatment discontinuation more in

Need to collect a #SuppOncSelfies 📸 with Deepak Vadehra every single ASCO meeting. Wonderful watching him rise as a #KoL in #GIonc and excited he's landed Roswell Park #ASCO25 Emre Yekedüz Dimitra R. Bakaloudi MD, MS, MPA Andrea Anampa-Guzmán (she/ella) Regina Barragan-Carrillo Corey Speers Enrique Grande Pauline Funchain

Testing again now that the plenary has happened #MATTERHORN #ASCO25

When you catch your fellows taking a selfie at #ASCO25, the APD is obligated to photobomb. UTSW Simmons Cancer Center Amy Little Jones, MD

The #GIOnc crew minus Nicholas Hornstein and Deepak Vadehra #ASCO25 has been brilliant so far! Tim Brown, MD MSCE Rohit Thummalapalli

Rohit Thummalapalli Nicholas Hornstein Deepak Vadehra Tim Brown, MD MSCE Haha I think you did better on this one 🤣

So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025 #ASCO25 1/10

Excellent talks and discussion on pancreatic cancer immunotherapy, vaccines and subtypes co-chaired by Tim Brown, MD MSCE Well planned 👍#ASCO2025

Proud of Gilbert Z Murimwa, M.D. for his publication in Cancer Research “SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition” Brekkenlab UTSW Simmons Cancer Center UTSW Surgery Residents aacrjournals.org/cancerres/arti…

Great poster session this morning with Nicolas Sayegh, MD highlighting work in #prostatecancer TMB & MSI-H w/ real world IO outcomes Foundation Medicine! Truly a star resident UTSW Simmons Cancer Center UTSW Internal Medicine co-mentored by me & Neeraj Agarwal, MD, FASCO. Look out for his fellowship apps this fall! #ASCO25

Insightful discussion on the keys to success for early-career oncologists Elisa Agostinetto ,Mina S. Sedrak Muhamad Alhaj Moustafa, MD, MS , Tim Brown, MD MSCE ASCO TECAG Hem-Onc Fellows Network IMG Oncologists

Last night at the Penn Medicine - Abramson Cancer Center reception! Wonderful representation ASCO #ASCO25 and we had with several faculty, fellows, alumni presenting science that can change practice! Penn Medicine MD Penn Medicine

It was a true pleasure to present at the ASCO TECAG Lounge at #ASCO25 on the Keys to Success for an Early Career Oncologist! 🔑 💫 Thanks to Tobe for the excellent moderation and to the entire panel Mina S. Sedrak Muhamad Alhaj Moustafa, MD, MS Tim Brown, MD MSCE ASCO OncoAlert

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study - The Lancet Oncology ⁦OncoAlert⁩ #ASCO25 thelancet.com/journals/lanon…

Data are in, 87% believe D-FLOT (s/o Sam Klempner) is now SOC

Udhayvir Grewal Tim Brown, MD MSCE Sam Klempner Yes similar incidence of G3+ though different AE profiles on ESOPEC G3+ AE with ≥ 5% incidence FLOT: neutropenia (20%), diarrhea (7%), leukopenia (6%), and pneumonia (6%) CROSS: pneumonia (9%) High risk cT2N0 GEJ is an interesting subset to consider